Effects of chemotherapy on patients with unresectable or metastatic adenocarcinoma of gallbladder

Journal of the Pakistan Medical Association

Volumn 57, Issue 2, 2007, Pages 71-74

  Qayyum, Abdul ^a   Mujtaba, Iqbal ^a  

^a Patel Hospital   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; VITAMIN B COMPLEX;

ALOPECIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; GALLBLADDER CARCINOMA; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; OUTCOME ASSESSMENT; SIDE EFFECT; STOMATITIS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMERONASAL ORGAN; ADENOCARCINOMA; GALLBLADDER TUMOR; PATHOLOGY; PROSPECTIVE STUDY;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; GALLBLADDER NEOPLASMS; HUMANS; LEUCOVORIN; MALE; PROSPECTIVE STUDIES; VITAMIN B COMPLEX;

EID: 34047246287     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Probl Surg 1995; 32 : 1-90.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36.
3. Hasan TJ, Zuberi SJ, Maqsood R. Carcinoma of Gallbladder: J Pak Med Assoc 1978; 38: 33-4.
4. de Aretxabala X, Roa I, Burgos L, Araya JC, Fonseca L, Wistuba I, et al. Gallbladder cancer in Chile. A report on 54 potentially resectable tumors. Cancer 1992; 69 : 60-5.
5. Vatanasapt V, Uttaravichien T, Mairiang EO, Pairojkul C, Chartbanchachai W, Haswell-Elkins M. Cholangiocarcinoma in north-east Thailand. Lancet 1990; 335: 116-171.
6. Ahmed M, Khan AH, Mansoor A. The pattern of malignant tumor in Northern Pakistan. J Pak Med Assoc 1991; 41: 270-3.
7. Cunningham CC, Zibari GB, Johnston LW. Primary carcinoma of the gall bladder: a review of our experience. J La State Med Soc 2002; 154: 196-9.
8. Tanaka K, Ikoma A, Hamada N, Nishida S, Kadono J, Taira A. Biliary tract cancer accompanied by anomalous junction of pancreaticobiliary ductal system in adults. Am J Surg 1998; 175: 218-20.
9. Sumiyoshi K, Nagai E, Chijiiwa K. Pathology of carcinoma of the gallbladder. World J Surg 1991; 15: 315-21.
10. Chao TC, Greager JA. Primary carcinoma of the gallbladder. J Surg Oncol 1991; 46: 215-21.
11. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Ann Surg 1994; 219: 275-280
12. de.Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A, et al. Chemoradiotherapy in gallbladder cancer. J Surg Oncol 2006; 93:699-704.
13. Takada T, Kato H, Matsushiro T, Nimura Y, Nagakawa T, Nakayama T. Comparison of 5-fluorouracil, doxorubicin, and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas. Oncology 1994; 51: 396-400.
14. Falkson G, Macintyre JM, Moertel CG. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bille duct cancer. Cancer 1984; 54: 965-9.
15. Von Eyben E, Hellekant C, Mattsson W, Ljungquist U, Jonsson K. Mitomycin-C in advanced gallbladder carcinoma. Acta Radiol Oncol 1980; 19: 81-4.
16. Ohta K, Sawamura A, Miyahara E, Kim R, Toge T. A case of inoperable advanced gallbladder cancer responding to5-fluorouracil (5-FU) and leucovorin (LV). Gan To Kagaku Ryoho 2001; 28: 516-19.
17. Madajewicz S, Hentschel P, Burns P, Caruso R, Fiore J, Fried M, Malhotra H, et al. Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil in patients with solid tumor malignancies. J Clin Oncol 2000; 18: 3553-7.
18. Chen JS, Jan YY, Lin YC, Wang HM, Chang WC, Liau CT. Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas. Anticancer Drugs 1998; 9: 393-7.
19. Malik IA, Aziz Z, Zaidi SHM, Sethuraman G. Gemcitabine and cisplatin is highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am J Clin Oncol 2003; 26: 174-7.
20. Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, et al. A phase II study of gemcitabine and cisplatin in chemotherapy-naïve, unresectable gall bladder cancer. Br J Cancer 2004; 90: 1516-20.